Nurse Practitioner, Adult Health · Lyndhurst, OH
NPI
1225129695
Since 2006
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
29001 Cedar Rd Ste 201
Lyndhurst, OH, 44124
Phone (440) 442-6000
Groups this clinician bills Medicare through
Medicare paid, 2024
$111K
18,356 services
Medicare patients, 2024
78
Average age 71
Drug cost, 2024
$561K
2,265 prescriptions
Company payments, 2025
$10K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Karen P Steffey was code J0585 (injection, onabotulinumtoxina, 1 unit), 17,700 times for 28 patients. In total Karen P Steffey billed 18,356 services in 17 codes, and Medicare paid $111K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-04-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 17,700 | 28 | $4.99 | $88K |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 164 | 18 | $0.49 | $80.66 |
| 99213 Office E&M - Established | Office | 132 | 70 | $52.30 | $6,904 |
| 64612 Musculoskeletal | Office | 51 | 19 | $62.07 | $3,166 |
| 64616 Musculoskeletal | Office | 51 | 19 | $119.48 | $6,094 |
| 96372 Injection Administration | Office | 49 | 19 | $8.66 | $424 |
| 64615 Musculoskeletal | Office | 43 | 22 | $101.56 | $4,367 |
| 99214 Office E&M - Established | Office | 17 | 13 | $67.87 | $1,154 |
By year: 2022 $110K for 17,750 services; 2023 $105K for 16,746 services; 2024 $111K for 18,356 services.
Medicare prescription drug claims, 2024
In 2024, the drug Karen P Steffey prescribed most often to Medicare patients was Cyclobenzaprine Hcl, with 166 prescriptions and refills. In total Karen P Steffey wrote 2,265 Medicare prescriptions that cost $561K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cyclobenzaprine Hcl Generic | 166 | 208 | 35 | $2,003 |
| Gabapentin Generic | 161 | 265 | 21 | $1,608 |
| Sumatriptan Succinate Generic | 159 | 209 | 31 | $17K |
| Rizatriptan Rizatriptan Benzoate | 125 | 145 | 25 | $2,056 |
| Emgality Pen Galcanezumab-Gnlm | 123 | 155 | 15 | $107K |
| Naratriptan Hcl Generic | 102 | 120 | 27 | $3,462 |
| Topiramate Generic | 93 | 191 | 19 | $646 |
| Nurtec Odt Rimegepant Sulfate | 77 | 77 | 15 | $100K |
| Tizanidine Hcl Generic | 75 | 163 | 20 | $831 |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 75 | 75 | 17 | $1,126 |
| Methylprednisolone Generic | 64 | 64 | 43 | $475 |
| Ubrelvy Ubrogepant | 60 | 66 | 15 | $79K |
| Zolmitriptan Generic | 52 | 53 | Under 11 | $6,528 |
| Aimovig Autoinjector Erenumab-Aooe | 52 | 71 | Under 11 | $52K |
| Duloxetine Hcl Generic | 48 | 114 | Under 11 | $799 |
Brand drugs: 461 claims; generic drugs: 1,804 claims; opioid claims: 43.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Karen P Steffey $10K ($10K in general payments such as food, travel and fees) from 7 companies. The largest payer was Pfizer Inc. with $4,020.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.